Escitalopram treatment of major depression in patients with temporal lobe epilepsy. A double-blind, placebo-controlled study.

Trial Profile

Escitalopram treatment of major depression in patients with temporal lobe epilepsy. A double-blind, placebo-controlled study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2011

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Jan 2009 Planned end date changed from 1 Dec 2008 to 1 Dec 2009 as reported by ClinicalTrials.gov.
    • 01 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top